My main research interest is in the field of pharmacoepidemiology. My current projects include studies of the risks and benefits of psychotropic medications (e.g., antidepressants, ADHD medication) using large-scale population data (e.g., national health registers, medical claim database).
As a separate research interest, I've also participated in a series of studies on the associations between mental and somatic disorders, using various data sources from Sweden, China, and the US.
Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release. Chang Z, Lichtenstein P, Långström N, Larsson H, Fazel S JAMA 2016 Nov;316(17):1798-1807
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study. Chang Z, D'Onofrio BM, Quinn PD, Lichtenstein P, Larsson H Biol. Psychiatry 2016 12;80(12):916-922
Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study. Chang Z, Lichtenstein P, Larsson H, Fazel S Lancet Psychiatry 2015 May;2(5):422-430
Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H JAMA Psychiatry 2014 Mar;71(3):319-25
Developmental twin study of attention problems: high heritabilities throughout development. Chang Z, Lichtenstein P, Asherson PJ, Larsson H JAMA Psychiatry 2013 Mar;70(3):311-8
- PhD in Psychiatric Epidemiology, Karolinska Institutet, 2013
- MSc in Biomedicine, Karolinska Institutet, 2009
- BSc in Life Science, Fudan University, 2007